Literature DB >> 32800941

The emerging molecular mechanisms for mitochondrial dysfunctions in FXTAS.

Dhruv Gohel1, Nicolas Charlet Berguerand2, Flora Tassone3, Rajesh Singh4.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is an inherited neurodegenerative disorder caused by an expansion of 55-200 CGG repeats at 5UTR of FMR1 gene, known as premutation. The main clinical and neuropathological features of FXTAS include progressive intention tremor, gait ataxia, neuronal cell loss and presence of ubiquitin-positive intranuclear inclusions in neurons and astrocytes. Various mitochondrial dysfunctions are reported in in vitro/vivo models of FXTAS; however, the molecular mechanisms underlying such mitochondrial dysfunctions are unclear. CGG expansions are pathogenic through distinct mechanisms involving RNA gain of function, impaired DNA damage repair and FMRpolyG toxicity. Here, we have systematically reviewed the reports of mitochondrial dysfunctions under premutation condition. We have also focused on potential emerging mechanisms to understand mitochondrial associated pathology in FXTAS. This review highlights the important role of mitochondria in FXTAS and other related disorders; and suggests focus of future studies on mitochondrial dysfunction along with other prevailing mechanisms to alleviate neurodegeneration.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  FMRpolyG; FXTAS; Inflammation; Mitochondrial dysfunctions; RNA gain of function; miRNAs

Mesh:

Year:  2020        PMID: 32800941     DOI: 10.1016/j.bbadis.2020.165918

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  2 in total

Review 1.  Lymphoblastoid Cell Lines as Models to Study Mitochondrial Function in Neurological Disorders.

Authors:  Sarah Jane Annesley; Paul Robert Fisher
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

Review 2.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): A Gender Perspective.

Authors:  Daniele Orsucci; Lucia Lorenzetti; Fulvia Baldinotti; Andrea Rossi; Edoardo Vitolo; Fabio Luigi Gheri; Alessandro Napolitano; Giancarlo Tintori; Marco Vista
Journal:  J Clin Med       Date:  2022-02-15       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.